Desvenlafaxine

FDA Drug Profile — Desvenlafaxine

Drug Details

Generic Name
Desvenlafaxine
Brand Names
Desvenlafaxine
Application Number
ANDA204082
Sponsor
American Health Packaging
NDC Codes
27
Dosage Forms
TABLET, FILM COATED, EXTENDED RELEASE, POWDER, TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
DESVENLAFAXINE SUCCINATE, DESVENLAFAXINE

Indications and Usage

1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablet is indicated for the treatment of adults with major depressive disorder (MDD) [see CLINICAL STUDIES ( 14 )]. Desvenlafaxine extended-release tablet, is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).